Drug Trial Radar · NCT03864614
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
Last checked: Nov 20, 2026Latest source record: Aug 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,515
Actual
Start
Feb 27, 2019
Primary completion
Jun 22, 2023
Study completion Jun 22, 2023
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Mar 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult participants with MDD.
Conditions
- Major Depressive Disorder
Interventions
SAGE-217Drug
SAGE-217
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: Up to 52 Weeks
- Part B: Number of Participants With TEAEsTime frame: Up to 46 Weeks
- Part A: Number of Participants With Suicidal Ideation (SI) or Suicidal Behavior (SB) as Assessed by the Columbia Suicide Severity Rating Scale (C-SSRS)Time frame: Baseline up to 52 Weeks (Study Period 1-5)
- Part B: Number of Participants With Suicidal Ideation (SI) and Suicidal Behavior (SB) as Assessed by the C-SSRSTime frame: Baseline up to 46 Weeks (Study Period 1-5)
Locations
52 sites in 1 country. Site status is shown where the registry gives one.
Sage Investigational Site
Dothan, Alabama
Sage Investigational Site
Phoenix, Arizona
Sage Investigational Site
Anaheim, California
Sage Investigational Site
Costa Mesa, California
Sage Investigational Site
Glendale, California
Sage Investigational Site
Irvine, California
Sage Investigational Site
Los Alamitos, California
Sage Investigational Site
Oceanside, California
Sage Investigational Site
Orange, California
Sage Investigational Site
Riverside, California
Sage Investigational Site
San Diego, California
Sage Investigational Site
Temecula, California
Sage Investigational Site
Colorado Springs, Colorado
Sage Investigational Site
Cromwell, Connecticut
Sage Investigational Site
Norwich, Connecticut
Sage Investigational Site
Coral Springs, Florida
Sage Investigational Site
Jacksonville, Florida
Sage Investigational Site
Miami, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Pensacola, Florida
Sage Investigational Site
Alpharetta, Georgia
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Marietta, Georgia
Sage Investigational Site
Savannah, Georgia
Sage Investigational Site
Chicago, Illinois
Sage Investigational Site
Chicago, Illinois
Sage Investigational Site
Watertown, Massachusetts
Sage Investigational Site
Ann Arbor, Michigan
Sage Investigational Site
Saint Charles, Missouri
Sage Investigational Site
Lincoln, Nebraska
Sage Investigational Site
Cherry Hill, New Jersey
Sage Investigational site
Marlton, New Jersey
Sage Investigational Site
Princeton, New Jersey
Sage Investigational Site
Albuquerque, New Mexico
Sage Investigational Site
Brooklyn, New York
Sage Investigational Site
Brooklyn, New York
Sage Investigational Site
Mount Kisco, New York
Sage Investigational Site
Beachwood, Ohio
Sage Investigational Site
Cincinnati, Ohio
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.